Media release

DKSH Partners with Sunward to Extend the Reach of Healthcare Products in Peninsular Malaysia

Back
DKSH Partners with Sunward to Extend the Reach of Healthcare Products in Peninsular Malaysia

DKSH has signed a partnership with Sunward to support the distribution and logistics needs for Sunward’s products in Peninsular Malaysia. DKSH is committed to improve the accessibility of their “Psychotropics and Dangerous Drugs” range throughout Peninsular Malaysia.

Petaling Jaya, Malaysia, June 26, 2024 – DKSH Business Unit Healthcare, a leading strategic partner for companies seeking to grow their healthcare business in Asia and beyond, has successfully entered into a strategic partnership with Sunward Pharmaceutical in Malaysia, with one of the largest generic pharmaceutical manufacturers in Singapore and Malaysia, to enhance the accessibility of Sunward’s five (5) high-quality products from their “Psychotropics and Dangerous Drugs” product range across Peninsular Malaysia.

This collaboration seeks to leverage DKSH Malaysia’s specialized expertise in market expansion services, optimizing the supply chain’s efficiency and ensuring seamless distribution of Sunward’s competitive and high-quality products across diverse distribution channels, such as independent pharmacies, private and public hospitals, and general practitioners. 

Jung Jiunn Der, Managing Director at Sunward, commented: “We have chosen DKSH Malaysia as our partner because we trust in their ability to advance our purpose of improving health and quality of life by ensuring accessibility to our top-quality products. This strategic partnership reflects our shared goals for growth and success, and with DKSH’s support, we look forward to collaborative efforts that will advance Sunward’s ongoing success.”

Sandeep Tewari, Head Country Management and Vice President Healthcare, DKSH Malaysia, added: “This partnership reflects our shared commitment to innovation, growth, and the delivery of exceptional pharmaceutical products to a wider audience. It exemplifies our commitment to supporting Malaysian pharmaceutical manufacturers and further underscores our commitment to providing healthcare for all to enrich people’s lives.”

About Sunward Pharmaceutical Sdn Bhd
Sunward Pharmaceutical Sdn Bhd (Sunward) was incorporated in 1968 with the purpose of improving health and quality of life through delivering the best-in-class products at competitive prices, for the betterment of society at large. Our company's headquarters is located in Singapore. As one of the largest generic pharmaceutical manufacturers in Singapore, Sunward specializes in the manufacturing of pharmaceutical products in various dosage forms, including liquids for ingestion and external administration, creams, plain and coated tablets, and capsules. With factories in Malaysia and Thailand, Sunward supplies innovative drugs comprising therapeutics and over the counter (OTC) medication, earning the trust of healthcare professionals and consumers globally. www.sunwardpharma.com

About DKSH 
DKSH’s purpose is to enrich people’s lives. For almost 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales ser-vices. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 29,040 specialists, generating net sales of CHF 11.1 billion in 2023. DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health, and over-the-counter products as well as medical devices. With around 8,140 specialists, the Business Unit generated net sales of CHF 5.6 bil-lion in 2023. www.dksh.com/hec

 

For more information please contact:

DKSH Holdings (Malaysia) Berhad
Christy Chow
Senior Manager, Marketing & Communications 
+60 16 232 3334
christy.hm.chow@dksh.com 

Kaylynn Yap
Specialist, Marketing & Communications
kaylynn.yap@dksh.com 

Downloads

Select a market